Valuation: Nippon Shinyaku Co., Ltd.

Market Cap 273B 1.68B 1.47B 1.36B 1.25B 2.36B 162B 2.4B 16.13B 6.36B 79.28B 6.3B 6.17B P/E 2027 *
9.29x
P/E 2028 * 18.5x
Enterprise Value 213B 1.31B 1.15B 1.06B 978M 1.85B 127B 1.88B 12.61B 4.97B 61.97B 4.93B 4.82B EV / Sales 2027 *
1.09x
EV / Sales 2028 * 1.01x
Free-Float
91.28%
Yield 2027 *
3.06%
Yield 2028 * 3.06%
Jul. 01 Jefferies Adjusts Nippon Shinyaku's Price Target to 4,300 Yen From 5,200 Yen, Keeps at Hold MT
Jun. 30 Jefferies Adjusts Nippon Shinyaku's Price Target to 4,300 Yen From 5,200 Yen, Keeps at Hold MT
Jun. 26 Nippon Shinyaku Co., Ltd. and Elixirgen Therapeutics, Inc. Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy CI
Jun. 23 Nippon Shinyaku Co., Ltd. and Boston Children's Hospital Announce Sponsored Research Agreement CI
May. 15 Dino Polska's Appetite, Ferragamo's Misstep Zonebourse
May. 14 Nippon Shinyaku Co., Ltd. Provides Consolidated Earnings Guidance for the First-Half Period and Full Year Fiscal Year Ending March 31, 2027 CI
May. 14 Nippon Shinyaku Co., Ltd. Proposes Year-End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 29, 2026 and Provides Dividend Guidance for the Second Quarter-End and Year-End Period of the Fiscal Year Ending March 31, 2027 CI
Mar. 13 Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss DJ
Mar. 10 Capricor Therapeutics, Inc. Establishes New PDUFA Date For Deramiocel BLA CI
Feb. 09 Nippon Shinyaku Co., Ltd. Announces Retirement of Takashi Takaya, Director, Personnel, General Affairs, Risk Management, Compliance & Digital Transformation CI
Feb. 08 Nippon Shinyaku Co., Ltd. Announces Dividend for Second Quarter Year Ending March 31, 2026 CI
Feb. 08 Nippon Shinyaku Co., Ltd. Provides Earnings Guidance for the Full Year Ending March 31, 2026 CI
Feb. 08 Nippon Shinyaku Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
1 day+1.45%
1 week-0.83%
Current month+0.80%
1 month+1.91%
3 months-20.50%
6 months-24.90%
Current year-28.35%
1 week 3,980
Extreme 3980
4,108
1 month 3,932
Extreme 3932
4,179
Current year 3,913
Extreme 3913
5,787
1 year 3,020
Extreme 3020
6,529
3 years 2,694
Extreme 2694
6,784
5 years 2,694
Extreme 2694
9,840
10 years 2,694
Extreme 2694
10,360
Manager TitleAgeSince
Director of Finance/CFO - -
President 54 2021-05-31
Compliance Officer - 2026-06-30
Director TitleAgeSince
Chairman 73 2021-05-31
Director/Board Member 62 2018-05-31
Director/Board Member 54 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.45%-0.83%+30.24%-26.75% 1.68B
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.52%-0.95%+33.38%+38.39% 284B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
Average -0.13%+0.40%+27.25%+43.28% 357.67B
Weighted average by Cap. +0.29%+0.02%+35.25%+75.53%

Financials

2027 *2028 *
Net sales 196B 1.2B 1.06B 976M 897M 1.69B 116B 1.72B 11.57B 4.56B 56.86B 4.52B 4.42B 188B 1.15B 1.01B 935M 860M 1.62B 111B 1.65B 11.09B 4.37B 54.51B 4.33B 4.24B
Net income 28.77B 177M 155M 143M 132M 249M 17.07B 253M 1.7B 670M 8.36B 665M 650M 14.78B 90.92M 79.7M 73.7M 67.75M 128M 8.77B 130M 874M 344M 4.29B 342M 334M
Net Debt -59.58B -366M -321M -297M -273M -516M -35.35B -524M -3.52B -1.39B -17.31B -1.38B -1.35B -83.59B -514M -451M -417M -383M -724M -49.6B -736M -4.94B -1.95B -24.29B -1.93B -1.89B
Logo Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals and functional foods. The Company has two business segments. The Pharmaceutical Business segment conducts research and development in three focus areas: hematology, intractable and rare diseases (pulmonary arterial hypertension, muscular dystrophy, etc.), and urological and gynecological diseases. The Functional Food Business segment conducts research and development mainly in three categories: health food ingredients, quality-stabilizing preservatives, and protein preparations. Other businesses include business support, non-life insurance agency and life insurance solicitation, real estate rental, and educational support services.
Employees
2,309
Date Price Change Volume
26-07-17 ¥4,048.00 +1.45% 264,700
26-07-16 ¥3,990.00 -0.57% 171,300
26-07-15 ¥4,013.00 -0.99% 210,500
26-07-14 ¥4,053.00 +0.52% 155,900
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4,048.00JPY
Average target price
5,385.71JPY
Spread / Average Target
+33.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4516 Stock